Flare Therapeutics

Flare Therapeutics

  • 11-50 Employees
  • $123M Series B on 2023-03

Careers at Flare Therapeutics


About Flare Therapeutics

Flare Therapeutics is pioneering the field of drug discovery by focusing on transcription factors. The company aims to revolutionize disease treatment through its unique discovery engine that combines genetic, biochemical, and chemical insights to identify druggable pockets in transcription factors. Flare Therapeutics is initially targeting precision oncology, developing small molecules to restore transcriptional control disrupted by cancer.